Patents by Inventor Robert S. Munson, Jr.

Robert S. Munson, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9987343
    Abstract: The invention described herein relates to a Haemophilus influenzae (H. influenzae) regulon encoding type IV pili. In particular, the invention relates to type IV pili from nontypeable H. influenzae (NTHi) and from H. influenzae strains a, b, c, e and f. The invention provides isolated H. influenzae pilus polynucleotides and polypeptides encoded by the polynucleotides as well as polynucleotides and polypeptides encoded by the polynucleotides involved in the assembly/disassembly of the structure. The invention also relates to uses of these polynucleotides and/or polypeptides including methods for eliciting an immune response to H. influenzae and methods of treating and preventing H. influenzae related pathological conditions.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: June 5, 2018
    Assignee: NATIONWIDE CHILDREN'S HOSPITAL, INC.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, Jr.
  • Publication number: 20170106075
    Abstract: The invention described herein relates to a Haemophilus influenzae (H. influenzae) regulon encoding type IV pili. In particular, the invention relates to type IV pili from nontypeable H. influenzae (NTHi) and from H. influenzae strains a, b, c, e and f. The invention provides isolated H. influenzae pilus polynucleotides and polypeptides encoded by the polynucleotides as well as polynucleotides and polypeptides encoded by the polynucleotides involved in the assembly/disassembly of the structure. The invention also relates to uses of these polynucleotides and/or polypeptides including methods for eliciting an immune response to H. influenzae and methods of treating and preventing H. influenzae related pathological conditions.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 20, 2017
    Inventors: Lauren O. Bakaletz, Robert S. Munson, JR.
  • Patent number: 9533033
    Abstract: The invention described herein relates to a Haemophilus influenzae (H. influenzae) regulon encoding type IV pili. In particular, the invention relates to type IV pili from nontypeable H. influenzae (NTHi) and from H. influenzae strains a, b, c, e and f. The invention provides isolated H. influenzae pilus polynucleotides and polypeptides encoded by the polynucleotides as well as polynucleotides and polypeptides encoded by the polynucleotides involved in the assembly/disassembly of the structure. The invention also relates to uses of these polynucleotides and/or polypeptides including methods for eliciting an immune response to H. influenzae and methods of treating and preventing H. influenzae related pathological conditions.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: January 3, 2017
    Assignee: NATIONWIDE CHILDREN'S HOSPITAL, INC.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, Jr.
  • Publication number: 20160289278
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable strain of Haemophilus influenza (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Application
    Filed: June 9, 2016
    Publication date: October 6, 2016
    Inventors: Lauren O. Bakaletz, Robert S. Munson, JR., David W. Dyer
  • Publication number: 20160175424
    Abstract: The invention described herein relates to a Haemophilus influenzae (H. influenzae) regulon encoding type IV pili. In particular, the invention relates to type IV pili from nontypeable H. influenzae (NTHi) and from H. influenzae strains a, b, c, e and f. The invention provides isolated H. influenzae pilus polynucleotides and polypeptides encoded by the polynucleotides as well as polynucleotides and polypeptides encoded by the polynucleotides involved in the assembly/disassembly of the structure. The invention also relates to uses of these polynucleotides and/or polypeptides including methods for eliciting an immune response to H. influenzae and methods of treating and preventing H. influenzae related pathological conditions.
    Type: Application
    Filed: March 7, 2016
    Publication date: June 23, 2016
    Inventors: Lauren O. Bakaletz, Robert S. Munson, JR.
  • Patent number: 9309294
    Abstract: The invention described herein relates to a Haemophilus influenzae (H. influenzae) regulon encoding type IV pili. In particular, the invention relates to type IV pili from nontypeable H. influenzae (NTHi) and from H. influenzae strains a, b, c, e and f. The invention provides isolated H. influenzae pilus polynucleotides and polypeptides encoded by the polynucleotides as well as polynucleotides and polypeptides encoded by the polynucleotides involved in the assembly/disassembly of the structure. The invention also relates to uses of these polynucleotides and/or polypeptides including methods for eliciting an immune response to H. influenzae and methods of treating and preventing H. influenzae related pathological conditions.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: April 12, 2016
    Assignee: NATIONWIDE CHILDREN'S HOSPITAL, INC.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, Jr.
  • Publication number: 20150218231
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable strain of Haemophilus influenza (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Application
    Filed: April 15, 2015
    Publication date: August 6, 2015
    Inventors: Lauren O. Bakaletz, Robert S. Munson, JR., David W. Dyer
  • Patent number: 9034642
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable strain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Grant
    Filed: January 9, 2014
    Date of Patent: May 19, 2015
    Assignees: NATIONWIDE CHILDREN'S HOSPITAL, THE BOARD OF REGENTS OF UNIVERSITY OF OKLAHOMA
    Inventors: Lauren O. Bakaletz, Robert S. Munson, Jr., David W. Dyer
  • Publication number: 20150118262
    Abstract: The invention described herein relates to a Haemophilus influenzae (H. influenzae) regulon encoding type IV pili. In particular, the invention relates to type IV pili from nontypeable H. influenzae (NTHi) and from H. influenzae strains a, b, c, e and f. The invention provides isolated H. influenzae pilus polynucleotides and polypeptides encoded by the polynucleotides as well as polynucleotides and polypeptides encoded by the polynucleotides involved in the assembly/disassembly of the structure. The invention also relates to uses of these polynucleotides and/or polypeptides including methods for eliciting an immune response to H. influenzae and methods of treating and preventing H. influenzae related pathological conditions.
    Type: Application
    Filed: January 9, 2015
    Publication date: April 30, 2015
    Inventors: LAUREN O. BAKALETZ, ROBERT S. MUNSON, JR.
  • Publication number: 20140199350
    Abstract: Provided are delivery systems for topically administering a chimeric protein including the NTHi twitching pilus major subunit protein (PilA) presenting a portion of the NTHi OMP P5 protein. Also provided are methods for eliciting a response by administrating the delivery systems to a subject.
    Type: Application
    Filed: March 10, 2014
    Publication date: July 17, 2014
    Applicant: Research Institute at Nationwide Children's Hospital
    Inventors: Lauren O. BAKALETZ, Robert S. MUNSON, Jr.
  • Patent number: 8741304
    Abstract: The invention described herein relates to a chimeric protein comprising the NTHi twitching pilus major subunit protein (PilA) presenting a portion of the NTHi OMP P5 protein. The invention provides for vaccine compositions comprising the recombinant chimeric protein and methods of eliciting an immune response using the recombinant chimeric proteins of the invention.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: June 3, 2014
    Inventors: Lauren O. Bakaletz, Robert S. Munson, Jr.
  • Publication number: 20140127221
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable strain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Application
    Filed: January 9, 2014
    Publication date: May 8, 2014
    Applicant: NATIONWIDE CHILDREN'S HOSPITAL, INC.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, JR., David W. Dyer
  • Publication number: 20140120107
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Application
    Filed: December 23, 2013
    Publication date: May 1, 2014
    Applicants: The Board of Regents of University of Oklahoma, Nationwide Children's Hospital, Inc.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, JR., David W. Dyer
  • Patent number: 8652773
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: February 18, 2014
    Assignee: Nationwide Children's Hospital, Inc.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, Jr., David W. Dyer
  • Patent number: 8628917
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: January 14, 2014
    Assignees: Nationwide Children's Hospital, Inc., The Board of Regents of the University of Oklahoma, Children's Hosptial Inc.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, Jr., David W. Dyer
  • Publication number: 20130078254
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Application
    Filed: September 12, 2012
    Publication date: March 28, 2013
    Applicant: NATIONWIDE CHILDREN'S HOSPITAL, INC.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, JR., David W. Dyer
  • Patent number: 8399000
    Abstract: The invention described herein relates to a Haemophilus influenzae (H. influenzae) regulon encoding type IV pili. In particular, the invention relates to type pili from nontypeable H. influenzae (NTHi) and from H. influenzae strains a, b, c, e and f. The invention provides isolated H. influenzae pilus polynucleotides and polypeptides encoded by the polynucleotides as well as polynucleotides and polypeptides encoded by the polynucleotides involved in the assembly/disassembly of the structure. The invention also relates to uses of these polynucleotides and/or polypeptides including methods for eliciting an immune response to H. influenzae and methods of treating and preventing H. influenzae related pathological conditions.
    Type: Grant
    Filed: January 12, 2011
    Date of Patent: March 19, 2013
    Assignee: Nationwide Children's Hospital, Inc.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, Jr.
  • Publication number: 20130064828
    Abstract: The invention described herein relates to a chimeric protein comprising the NTHi twitching pilus major subunit protein (PilA) presenting a portion of the NTHi OMP P5 protein. The invention provides for vaccine compositions comprising the recombinant chimeric protein and methods of eliciting an immune response using the recombinant chimeric proteins of the invention.
    Type: Application
    Filed: September 10, 2012
    Publication date: March 14, 2013
    Applicant: Nationwide Children's Hospital, Inc.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, JR.
  • Publication number: 20130017204
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Application
    Filed: July 19, 2012
    Publication date: January 17, 2013
    Applicants: THE BOARD OF REGENTS OF UNIVERSITY OF OKLAHOMA, NATIONWIDE CHILDREN'S HOSPITAL, INC.
    Inventors: Lauren O. Bakaletz, Robert S. Munson, JR., David W. Dyer
  • Patent number: 8283114
    Abstract: The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.
    Type: Grant
    Filed: June 15, 2006
    Date of Patent: October 9, 2012
    Assignees: Nationwide Children's Hospital, Inc., The Board of Regents of University of Oklahoma
    Inventors: Lauren O. Bakaletz, Robert S. Munson, Jr., David W. Dyer